A Forgotten Cause of Recurrent Abdominal Pain: Case Report
DOI:
https://doi.org/10.22516/25007440.1110Keywords:
Hepatic porphyria, Hemin, Abdominal painAbstract
Introduction: Porphyrias are enzymatic disorders of heme synthesis. Acute hepatic porphyrias (AHP) presents with acute neurovisceral symptoms such as abdominal pain, nausea, vomiting, constipation, muscle weakness, neuropathy, tachycardia, and hypertension. 5-aminolevulinic acid dehydratase (ALAD) deficiency is a rare autosomal recessive disorder that results in little or no elevation of porphobilinogen but elevates urinary 5-aminolevulinic acid and coproporphyrin III. There are no records of this type of porphyria in Colombia. Acute management requires comprehensive care, ranging from hemotherapy to liver transplantation.
Case Presentation: A 24-year-old man with no prior medical history presented with a recurrent and acute episode of abdominal pain associated with changes in urine color, skin lesions, diarrhea, and dysregulation of body temperature. Initial paraclinical workup ruled out common causes of recurrent abdominal pain, with a negative porphobilinogen test, but further testing revealed elevated 5-aminolevulinic acid, confirming the diagnosis of ALAD porphyria. The patient showed improvement with hemotherapy and remission of acute kidney injury. A possible distractor associated with interstitial nephritis and skin manifestations related to nonsteroidal anti-inflammatory drug (NSAID) use was documented.
Conclusions: ALAD porphyria and all acute hepatic porphyrias should be considered in any patient presenting with unexplained recurrent severe abdominal pain and neuropathy. Despite their relative rarity and complexity, most porphyrias can be easily defined and diagnosed. A common cause of diagnostic delay is the failure to consider porphyria in the differential diagnosis on time. There is still much to learn about ALAD porphyria.
Downloads
References
Referencias
Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med [Internet]. 2017;377(9):862–72. Available from: http://dx.doi.org/10.1056/NEJMra1608634
Gerischer LM, Scheibe F, Nümann A, Köhnlein M, Stölzel U, Meisel A. Acute porphyrias - A neurological perspective. Brain Behav [Internet]. 2021;11(11):e2389. Available from: http://dx.doi.org/10.1002/brb3.2389
Bonkovsky HL, Dixon N, Rudnick S. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol Genet Metab [Internet]. 2019;128(3):213–8. Available from: http://dx.doi.org/10.1016/j.ymgme.2019.03.002
de Souza PVS, Badia B de ML, Farias IB, Pinto WBV de R, Oliveira ASB. Acute hepatic porphyria: Pathophysiological basis of neuromuscular manifestations. Front Neurosci [Internet]. 2021;15:715523. Available from: http://dx.doi.org/10.3389/fnins.2021.715523
Stölzel U, Doss MO, Schuppan D. Clinical guide and update on porphyrias. Gastroenterology [Internet]. 2019;157(2):365-381.e4. Available from: http://dx.doi.org/10.1053/j.gastro.2019.04.050
Wang B, Bonkovsky HL, Lim JK, Balwani M. AGA clinical practice update on diagnosis and management of acute hepatic porphyrias: Expert review. Gastroenterology [Internet]. 2023;164(3):484–91. Available from: http://dx.doi.org/10.1053/j.gastro.2022.11.034
Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: Review and recent progress: Hepatology communications. Hepatol Commun [Internet]. 2019;3(2):193–206. Available from: http://dx.doi.org/10.1002/hep4.1297
Anderson KE, Lobo R, Salazar D, Schloetter M, Spitzer G, White AL, et al. Biochemical diagnosis of acute hepatic porphyria: Updated expert recommendations for primary care physicians. Am J Med Sci [Internet]. 2021;362(2):113–21. Available from: http://dx.doi.org/10.1016/j.amjms.2021.03.004
Rigor J, Pinto SA, Martins-Mendes D. Porphyrias: A clinically based approach. Eur J Intern Med [Internet]. 2019;67:24–9. Available from: http://dx.doi.org/10.1016/j.ejim.2019.06.014

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |